James Colandene

Title: The Innovative Contributions of James Colandene

Introduction

James Colandene is an accomplished inventor based in Raleigh, NC (US). He has made significant contributions to the field of biotherapeutics, particularly through his innovative patent related to plasmin treatment. His work is characterized by a commitment to advancing medical solutions that can improve patient outcomes.

Latest Patents

Colandene holds a patent for a method titled "Reversibly inactivated acidified plasmin." This method involves administering a composition that includes a reversibly inactivated acidified plasmin, which is substantially free of a plasminogen activator. The composition is designed to be suitable for pharmaceutical use and can be raised to physiological pH by adding no more than about five volumes of serum to the solution relative to a volume of the solution. This innovative approach has the potential to enhance treatment options for various medical conditions.

Career Highlights

Colandene is currently associated with Talecris Biotherapeutics, Inc., where he continues to develop and refine his innovative ideas. His work at Talecris has positioned him as a key player in the biotherapeutics industry, contributing to advancements that can lead to improved therapies for patients.

Collaborations

Throughout his career, Colandene has collaborated with notable colleagues, including Thomas P. Zimmerman and Valery Novokhatny. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the field of biotherapeutics.

Conclusion

James Colandene's contributions to the field of biotherapeutics through his innovative patent and collaborative efforts highlight his dedication to improving medical treatments. His work exemplifies the impact that inventors can have on healthcare and the importance of innovation in advancing medical science.